Molecule Information
General Information of the Molecule (ID: Mol02075)
Name |
NADH dehydrogenase [ubiquinone] flavoprotein 1 (TbAT1)
,Trypanosoma brucei
|
||||
---|---|---|---|---|---|
Synonyms |
Tb927.5.450b
Click to Show/Hide
|
||||
Molecule Type |
Protein
|
||||
Gene Name |
TbAT1
|
||||
Sequence |
MLRRVGFLSATGSLLQAAASQQPPTQQEQRVHGGLKDQDRIFVNLYQDFGTDIDSAERRG
DWYRTRDLLLKGHDWVINEIKASGLRGRGGAGFPSGLKWSFMPKSKPDGRPSYIVVNGDE SEPGTCKDREIMRHEPHKLVEGALIAGFAMRARYGYIYIRGEFYNEWRAVDQAIKEAYAR GYLGRNACGSGYDFDLYTYCGAGAYICGEETAMISSIEGGPGKPRLKPPFPANVGLYGCP TTVTNVETVSVSPTILRRGPSWFNSFGRRNNAGVKLFCICGHVNRPCTVEEEMSIPLRDL IERHAGGVRGGWDNLLAVIPGGSSCPLIPKSICDNVLMDFDALKEAQTGLGTAAVIVMDK STDLIAAIHRLSMFYAHESCGQCTPCREGSPWLEKMMQRFVHGNARMEEVGTMLDVSKQL EGRTICALATAAAWPVQGLARHFTPLLQERIEKYWEANPHWGKSGSPWRRWKTHRYYAMQ KGEKLNWDGKIVRNWN Click to Show/Hide
|
||||
Function |
Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor. Essential for the catalytic activity and assembly of complex I.
Click to Show/Hide
|
||||
Uniprot ID | |||||
Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
UAPP: Unusual Activation of Pro-survival Pathway
Drug Resistance Data Categorized by Drug
Approved Drug(s)
1 drug(s) in total
Pentamidine
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Unusual Activation of Pro-survival Pathway (UAPP) | ||||
Disease Class: African trypanosomiasis | [1] | |||
Resistant Disease | African trypanosomiasis [ICD-11: 1F51.0] | |||
Resistant Drug | Pentamidine | |||
Molecule Alteration | Expression | Down-regulation |
||
Experimental Note | Discovered Using In-vivo Testing Model | |||
In Vitro Model | Trypanosoma brucei strain | 5691 | ||
Mechanism Description | Reduced uptake and cross-resistance were apparently explained by the findings that melamine-based arsenicals and diamidines are imported into trypanosomes by the same transporter, and that this transporter is defective in drug-resistant cells. The transporter was called P2 (purine transporter 2) as its physiological substrates are adenine and adenosine, both of which compete with melarsoprol for uptake and can protect trypanosomes from melarsoprol-induced lysis. |
Investigative Drug(s)
1 drug(s) in total
Melamine-based arsenicals
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Unusual Activation of Pro-survival Pathway (UAPP) | ||||
Disease Class: African trypanosomiasis | [1] | |||
Resistant Disease | African trypanosomiasis [ICD-11: 1F51.0] | |||
Resistant Drug | Melamine-based arsenicals | |||
Molecule Alteration | Expression | Down-regulation |
||
Experimental Note | Discovered Using In-vivo Testing Model | |||
In Vitro Model | Trypanosoma brucei strain | 5691 | ||
Mechanism Description | Reduced uptake and cross-resistance were apparently explained by the findings that melamine-based arsenicals and diamidines are imported into trypanosomes by the same transporter, and that this transporter is defective in drug-resistant cells. The transporter was called P2 (purine transporter 2) as its physiological substrates are adenine and adenosine, both of which compete with melarsoprol for uptake and can protect trypanosomes from melarsoprol-induced lysis. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.